What's Behind the Rise in "Ozempic Divorce"?

"Ozempic, Zepbound, and other GLP-1 treatments are examples of "biopsychosocial medicines" with systemic effects on the user. Most prescription medicines target specific medical (e.g., a statin for lowering cholesterol), psychiatric (e.g., antidepressants), or behavioral conditions (e.g., ADHD medicines such"

"Many people who take GLP-1 drugs report renewed confidence, rewired priorities, even major relationship changes with food and the people they care about-including their own spouses. After months of "successful" GLP-1 treatment, many medication users are surprised to learn that the person their partner once knew is different, and that the building tension is now straining the foundation of their marriage."

"If this is familiar, deciding whether to prioritize your health or your marriage likely seems like an impossible choice. You're gaining energy and fitness, but you may also feel like you're also losing a critical connection. Perhaps worst of all, you may not know how to explain these changes to your spouse or how to navigate this new dynamic together."

"GLP-1 medicine could potentially affect a couple's divorce risk through several biopsychosocial mechanisms. As GLP-1 medicines grow in use, including education about relationship changes is advised."

GLP-1 medications can improve health outcomes such as blood sugar control, reduced food cravings, and increased energy, but they may also trigger invisible changes in priorities and confidence. Many users report altered relationships with food and with people they care about, including spouses. Over months of treatment, partners may experience tension as the person they knew becomes different. Weight loss and divorce have long been linked, and GLP-1 use has brought renewed attention to that association. GLP-1 medicines may affect divorce risk through multiple biopsychosocial pathways, including psychological and social changes. As use expands, education about potential relationship changes is recommended.

Read at Psychology Today